KV

Kishori Vaibhav Kanodia

Active Director Director DIN 09573053
DIN 09573053 First appointment Apr 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2022
Shareholding value •••• Premium profile

About Kishori Vaibhav Kanodia

Data last updated:

Kishori Vaibhav Kanodia is a Director at Naksha Pharmaceuticals Private Limited (since 2022). The company operates in Pharma. Naksha Pharmaceuticals Private Limited reported revenue of ₹40.24 Cr (FY 2025).

DIN 09573053
Primary Designation Director
Industry Pharma
First Appointment 15 Apr 2022
Oldest Company Age 4 yrs
Largest company Naksha Pharmaceuticals Private Limited · ₹40.24 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Apr 20222022₹40.24 Cr (FY 2025)Active

Board colleagues of Kishori Vaibhav Kanodia

Directorship timeline

Open interactive timeline →
Naksha Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Kishori Vaibhav Kanodia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kishori Vaibhav Kanodia

Kishori Vaibhav Kanodia currently holds 1 directorship: Naksha Pharmaceuticals Private Limited (Director, since 15 Apr 2022, revenue ₹40.24 Cr (FY 2025)).

Kishori Vaibhav Kanodia was first appointed on 15 Apr 2022 as Director at Naksha Pharmaceuticals Private Limited.

The current boards of Kishori Vaibhav Kanodia's companies include Kapilkumar Rajendraprasad Sharma (Naksha Pharmaceuticals Private Limited), Vaibhav Mahendra Kanodia (Naksha Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available